Velvet Rx Review

Velvet Rx: a price-forward compounded GLP-1 shop that asks you to trust it on faith

Velvet Rx (velvetrx.com) is a cash-pay telehealth platform built around one selling point: it puts its prices on the page. That alone makes it stand out. Most compounded GLP-1 sellers bury the real number behind a quiz, an email gate, or a 'starting at' teaser. Velvet Rx instead lists three flat monthly plans you can read in five seconds — compounded semaglutide, compounded tirzepatide, and an oral GLP-1 — each with a promo first month and a regular ongoing rate printed side by side. If transparent pricing is what makes you click 'start,' this provider is genuinely easy to shop. The catch is that the transparency stops at the price tag, and that is the whole story of whether Velvet Rx is worth it for you.

How the three-SKU pricing actually works

There is no membership fee and no dose-based markup here. Velvet Rx runs a flat model — its own page says 'Same price, every dose' — so you pay the same monthly figure whether you are titrating up early or sitting at a maintenance dose later. Each plan is a single bundle, not an a-la-carte stack. The headline entry point is a first-month promo of $139 on compounded semaglutide; the injectable tirzepatide plan promos at just under two hundred, and the oral GLP-1 at the high one-eighties. After that first month the regular rates kick in: semaglutide lands just under three hundred a month, tirzepatide in the high three-hundreds, and the oral plan around three-fifty. For context, the category median across comparable cash-pay compounded providers sits near $169, so Velvet Rx's promo months undercut the field while its regular rates are middle-of-the-pack.

One honest warning before you budget around the teaser: the promo is a first-month rate, not your standing cost. Plan for the regular monthly number, because that is what you will actually pay from month two onward.

What every plan includes

Whichever SKU you pick, the monthly price is meant to cover the whole loop rather than just the vial. Per Velvet Rx's verbatim plan copy, every plan bundles:

• A doctor consult and a written prescription
• Four weeks of medication shipped to you
• Free 1–2 day shipping
• Unlimited 1:1 medical support, described as 24/7 access to the medical team

It is cash-pay only, with no insurance billing — but the plans are FSA/HSA eligible, so you can run them through a tax-advantaged health account. There are no labs or structured coaching baked in; 'unlimited 1:1 support' is medical-team access, not a weight-loss coaching program, so treat it as troubleshooting and dose questions rather than a behavior-change service.

The oral GLP-1 that won't tell you what it is

Velvet Rx's most interesting differentiator is also its most frustrating. Almost no cash-pay compounder offers an oral GLP-1 alongside both injectables under one roof, and on paper that's a real convenience — pills appeal to needle-averse patients. But Velvet Rx never names the drug. The page calls it only 'Oral GLP-1.' That matters more than it sounds, because oral GLP-1 is not one thing: brand Rybelsus, newer oral entrants, and compounded oral semaglutide are clinically and legally distinct in their dosing, their absorption rules, and their regulatory standing. You should not pay for and swallow a daily GLP-1 without knowing exactly which molecule it is. If you are drawn to the oral plan, make confirming the specific active ingredient — in writing, before you pay — your first question to their medical team.

Where the transparency runs out

Pricing is the one area where Velvet Rx over-delivers. Almost everywhere else, it under-discloses. As of our 2026 verification the site showed no LegitScript certification and no NABP .pharmacy seal — the two badges that signal a vetted online pharmacy. It does not name a legal corporate entity beyond 'VelvetRx' in the footer, lists no physical address, never names the compounding pharmacy that fills its prescriptions, and publishes no list of which states it serves. Its marketing also leans on success-rate percentages with no stated methodology or sample size, which is the kind of number you should mentally discount to zero. None of this is an FDA red flag — a warning-letter search returned nothing on Velvet Rx — but absence of a problem is not the same as proof of rigor. The right read is medium confidence on the pricing and plan inclusions, and lower confidence on who is actually behind the operation and where the medication comes from.

Who should choose it — and who should walk

Velvet Rx is a reasonable fit if you are a confident, price-driven shopper who already understands compounded GLP-1s, wants an injectable semaglutide or tirzepatide plan with shipping bundled in, and is comfortable doing your own due diligence on a thinly documented company. The flat 'same price, every dose' model is genuinely friendly to anyone planning to titrate up over time.

Skip it if you need the reassurance of a named, accredited pharmacy and a disclosed corporate entity; if you want the oral option and won't accept an unnamed drug; if you need to confirm service in your state before committing; or if you're new to GLP-1s and want a provider that holds your hand with labs and structured coaching. Buyers who value institutional trust signals over a low sticker price will be happier elsewhere.

Bottom line

Velvet Rx earns real credit for doing the one thing the compounded-GLP-1 industry hates to do: showing its prices, across three plans, with the bundle spelled out. For an experienced, self-directed buyer chasing a clean monthly number on compounded semaglutide or tirzepatide, that makes it worth a look — especially during the promo first month. But it pairs that openness with unusual silence about its pharmacy, its corporate identity, its state coverage, and even the exact drug in its oral plan. Until those gaps close, treat Velvet Rx as a price-first option you verify carefully, not a turnkey, trust-it-blindly clinic. Read how we weigh these trade-offs in our scoring methodology before you commit.

For a side-by-side, HealthRX ($133/month) and bmiMD ($99/month) are the most comparable options to weigh against Velvet Rx.